Skip to content
Colorectal Cancer Clinical Trials

Salt Lake City, Utah

Colorectal cancer clinical trials in Salt Lake City, UT

32 colorectal cancer studies are recruiting participants at sites in Salt Lake City as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Salt Lake City at a glance

  • 32 studies are recruiting at a site in Salt Lake City.
  • By phase: Phase 1 (7), Phase 1/2 (9), Phase 2 (4), Phase 2/3 (1), Phase 3 (1), No phase (5), Observational (5). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (21), university, hospital or other (11).
  • Most recent update to one of these records: November 13, 2026.

Studies recruiting in Salt Lake City

Basic details from each study's public record (the 30 most recently updated of 32). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Study site
    Huntsman Cancer Institute University of Utah
    Registry record
    NCT07488676 · updated
  2. A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kestrel Therapeutics, Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT07458347 · updated
  3. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Huntsman Cancer Institute - University of Utah
    Registry record
    NCT07659795 · updated
  4. A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT07020221 · updated
  5. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  6. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    George E Wahlen Department of Veterans Affairs Medical Center
    Registry record
    NCT05080673 · updated
  7. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Huntsman Cancer Institute/University of Utah · LDS Hospital · Utah Cancer Specialists-Salt Lake City
    Registry record
    NCT05174169 · updated
  8. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Huntsman Cancer Institute/University of Utah
    Registry record
    NCT05673148 · updated
  9. A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Kumquat Biosciences Inc.
    Study site
    University of Utah - Huntsman Cancer Institute
    Registry record
    NCT07542704 · updated
  10. A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Genmab
    Study sites
    University of Utah Health Huntsman Cancer Hospital · Utah Cancer Specialists
    Registry record
    NCT03526835 · updated
  11. A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06330064 · updated
  12. JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Jacobio Pharmaceuticals Co., Ltd.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT06973564 · updated
  13. Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Delcath Systems Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06607458 · updated
  14. A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Dispatch Biotherapeutics
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT07544589 · updated
  15. Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

    • No phase
    • Ages 65 to 82
    • All sexes
    Sponsor
    Dartmouth-Hitchcock Medical Center
    Study site
    University of Utah
    Registry record
    NCT05612347 · updated
  16. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06445062 · updated
  17. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Aktis Oncology, Inc.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT07020117 · updated
  18. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Guardant Health, Inc.
    Study site
    Utah Cancer Specialists
    Registry record
    NCT05059444 · updated
  19. A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    NSABP Foundation Inc
    Study site
    Huntsman Cancer Institute - University of Utah
    Registry record
    NCT07058012 · updated
  20. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    START Mountain Region
    Registry record
    NCT06131840 · updated
  21. A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Coherus Oncology, Inc.
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT06657144 · updated
  22. Increasing Germline Genetic Testing for Patients With Cancer

    • No phase
    • All ages
    • All sexes
    Sponsor
    Josh Peterson
    Study site
    University of Utah Health
    Registry record
    NCT07307664 · updated
  23. Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Recursion Pharmaceuticals Inc.
    Study site
    Huntsman Cancer Institute and University of Utah
    Registry record
    NCT05552755 · updated
  24. BBO-11818 in Adult Subjects With KRAS Mutant Cancer

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT06917079 · updated
  25. Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    AIDS Malignancy Consortium
    Study site
    Huntsman Cancer Institute, University of Utah
    Registry record
    NCT05663502 · updated
  26. Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Huntsman Cancer Institute
    Registry record
    NCT05379985 · updated
  27. Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Stanford University
    Study site
    George E. Wahlen Department of Veterans Affairs Medical Center
    Registry record
    NCT05297734 · updated
  28. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    START Center for Cancer Care - Mountain Region
    Registry record
    NCT06395519 · updated
  29. Improving Care for Rural Patients With Solid Tumors

    • No phase
    • Ages 18 to 99
    • All sexes
    Sponsor
    University of Colorado, Denver
    Study site
    Huntsman Cancer Institute at the University of Utah
    Registry record
    NCT04916990 · updated
  30. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Study site
    Massive Bio SYNERGY-AI site
    Registry record
    NCT03452774 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Salt Lake City, UT on ClinicalTrials.gov.

Ask about studies near Salt Lake City

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call